Summit Therapeutics 肺癌药遭美国监管机构拒绝批准
Summit Therapeutics said US regulators declined to approve its lung cancer medicine, setting back its quest to challenge the standard of care with a d...
AI 导读
Summit Therapeutics 表示,美国监管机构拒绝批准其肺癌药物,令其以一款源自中国的药物挑战标准疗法的计划受挫。